# Summit Therapeutics

> biopharmaceutical company

**Wikidata**: [Q113503453](https://www.wikidata.org/wiki/Q113503453)  
**Source**: https://4ort.xyz/entity/summit-therapeutics

## Summary  
Summit Therapeutics is a public biopharmaceutical company based in Menlo Park, California, focused on developing therapeutics for serious diseases with high unmet medical need. It became publicly traded on the Nasdaq stock exchange under the ticker symbol SMMT in March 2015.

## Key Facts  
- Founded in 2003  
- Publicly traded on Nasdaq under the ticker symbol SMMT since March 5, 2015  
- Headquartered in Menlo Park, California  
- Operates in the field of biopharmaceuticals  
- Official website: https://www.summittxinc.com/ (language: English)  
- Identified as an instance of a "public company"  
- Listed on Crunchbase with organization ID "summit-therapeutics"  
- Described on Wikidata as a "biopharmaceutical company"

## FAQs  

**What is Summit Therapeutics?**  
Summit Therapeutics is a biopharmaceutical company that develops novel therapeutics for serious diseases. It is publicly traded and headquartered in Menlo Park, California.

**When was Summit Therapeutics founded?**  
The company was incorporated in 2003.

**Where is Summit Therapeutics traded, and what is its stock symbol?**  
It is listed on the Nasdaq stock exchange under the ticker symbol SMMT, beginning on March 5, 2015.

**What industry does Summit Therapeutics operate in?**  
It operates in the biopharmaceutical industry, focusing on innovative treatments for unmet medical needs.

**Is there an official website for Summit Therapeutics?**  
Yes, the official website is https://www.summittxinc.com/, and it is in English.

**Is Summit Therapeutics a public or private company?**  
It is a public company, having gone public via an initial public offering and listing on Nasdaq.

## Why It Matters  
Summit Therapeutics plays a role in advancing treatments for serious diseases through its focus on biopharmaceutical innovation. As a public company, it contributes to capital market activity and offers investment opportunities in the healthcare sector. Its work supports broader efforts in drug development and translational medicine, aiming to address conditions with limited therapeutic options.

## Notable For  
- Being a publicly traded biopharmaceutical company since 2015  
- Focusing on high-impact therapeutic areas with unmet medical needs  
- Maintaining a presence on Nasdaq under the symbol SMMT  
- Operating from Menlo Park, a hub for biotech and pharmaceutical innovation  
- Being classified as both a public company and a biopharmaceutical enterprise  

## Body  

### Company Overview  
Summit Therapeutics is a biopharmaceutical company that develops and commercializes novel medicines. It was founded in 2003 and is headquartered in Menlo Park, California. The company went public and began trading on the Nasdaq Global Select Market on March 5, 2015, under the ticker symbol SMMT.

### Legal and Business Structure  
Summit Therapeutics is incorporated as a public company, a legal structure that allows it to offer securities to the general public. This classification enables it to raise capital through public markets, which supports its research and development activities. It is distinct from private companies due to its public trading status and regulatory obligations.

### Field of Work  
The company operates in the biopharmaceutical sector, focusing on the discovery, development, and commercialization of therapeutics for serious diseases. Its pipeline emphasizes novel mechanisms of action and targets areas with significant unmet medical need.

### Stock Exchange Listing  
Summit Therapeutics is listed on the Nasdaq stock exchange. It began trading on March 5, 2015, under the ticker symbol SMMT. This listing represents a key milestone in its corporate development, enabling broader investor participation and capital access.

### Headquarters and Geographic Presence  
The company is headquartered in Menlo Park, California. This location situates it within a major biotechnology and pharmaceutical cluster, facilitating access to talent, infrastructure, and collaborative opportunities.

### Digital Presence  
Summit Therapeutics maintains an official website at https://www.summittxinc.com/. The site is presented in English and serves as a primary source of corporate information, including investor relations materials and company updates.

### Data Identifiers and Classifications  
- Instance of: public company  
- Field of work: biopharmaceutical  
- Inception: 2003  
- Stock exchange: Nasdaq (start date: March 5, 2015; ticker: SMMT)  
- Headquarters: Menlo Park  
- Website language: English  
- Crunchbase ID: summit-therapeutics  
- Wikidata description: biopharmaceutical company  

### Regulatory and Market Context  
As a public company, Summit Therapeutics adheres to regulatory requirements for financial transparency and reporting. These obligations are typical of U.S. public companies listed on major exchanges like Nasdaq and are designed to protect investor interests and ensure market integrity.

### Industry Relevance  
Summit Therapeutics contributes to the biopharmaceutical industry by advancing therapeutic candidates through clinical development. Its public status allows it to access capital markets to fund research, development, and potential commercialization efforts. This aligns with broader trends in healthcare innovation and public-private collaboration in drug development.